Mitsubishi Tanabe Pharma America
Hidenori Todoroki currently serves as the Associate Director of Global Open Innovation at Mitsubishi Tanabe Pharma America, a position held since June 2022. Prior to this role, Hidenori Todoroki was the Chief Research Scientist at Mitsubishi Tanabe Pharma Corporation from April 2015 to May 2022. Hidenori Todoroki earned a Doctor of Philosophy in Pharmaceutical Sciences from The University of Tokyo, completing the degree in 2015.
This person is not in the org chart
This person is not in any teams
Mitsubishi Tanabe Pharma America
We are taking on the challenges of complex and debilitating conditions and are committed to meeting the needs of people suffering from serious and often life-threatening illnesses. Today, we are focused on driving scientific discovery in many areas. Our focus remains on bringing treatment to people living with ALS as we strive to make a meaningful difference in their lives. Many people living with amyotrophic lateral sclerosis (ALS) have unmet medical needs. We are committed to doing our best to find solutions that may help address those needs. We continue to expand our work to deepen our understanding of ALS, explore potential biomarkers to aid in further research and seek new answers. Every day we tackle tough challenges in science and medicine. Our teams work diligently to develop smart options that will enable healthcare providers to offer safe and effective treatments for devastating illnesses. Please see our LinkedIn community guidelines here: http://www.mt-pharma-america.com/pdf/LinkedIn-Community-Guidelines.pdf